Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
14.74
+0.41 (2.86%)
At close: Jun 26, 2025, 4:00 PM
14.65
-0.09 (-0.61%)
Pre-market: Jun 27, 2025, 4:57 AM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.51 billion as of June 27, 2025. Its market cap has decreased by -51.38% in one year.
Market Cap
1.51B
Enterprise Value
1.22B
1-Year Change
-51.38%
Ranking
Category
Stock Price
$14.74
Market Cap Chart
Since October 18, 2022, Biohaven's market cap has increased from $412.66M to $1.51B, an increase of 264.74%. That is a compound annual growth rate of 61.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.51B | -60.15% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 129.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.66B |
| Johnson & Johnson | 366.59B |
| AbbVie | 328.57B |
| Novo Nordisk | 309.67B |
| UnitedHealth Group | 274.90B |
| Abbott Laboratories | 240.22B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.15B |